Table 3.
Variable | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
OR | 95%CI | p | OR | 95%CI | p | |
Age | 0.997 | 0.973–1.021 | .787 | |||
Sex (Male) | 0.764 | 0.414–1412 | .391 | |||
HT | 1.496 | 0.769–2.908 | .235 | |||
DM | 0.756 | 0.407–1.404 | .376 | |||
CAD | 2.255 | 1.160–4.382 | .016 | 2.413 | 1.292–4.507 | .006 |
CHF | 1.324 | 0.692–2.535 | .396 | |||
LVH | 0.600 | 0.299–1.204 | .151 | |||
LAD | 1.049 | 1.002–1.100 | .043 | 1.042 | 0.995–1.092 | .080 |
CHA2DS2‐VASC score | 1.830 | 1.353–2.475 | <.001 | 1.706 | 1.330–2.189 | <.001 |
PAC | 1.638 | 1.283–2.092 | <.001 | 1.672 | 1.321–2.209 | <.001 |
Beta‐Blocker | 1.292 | 0.690–2.420 | .423 |
Bold values indicates p < .05 are statistically significant.
Abbreviations: CAD, coronary artery disease; CHF, congestive heart failure; DM, diabetes mellitus; HT, hypertension; LAD, left atrium diameter; LVH, left ventricular hypertrophy; PAC, premature atrial contraction.